Related references
Note: Only part of the references are listed.Role of neuroimmune circuits and pruritus in psoriasis
Marissa T. Ayasse et al.
EXPERIMENTAL DERMATOLOGY (2020)
Characteristics of Pruritus according to Morphological Phenotype of Psoriasis and Association with Neuropeptides and Interleukin-31
Sung-Min Park et al.
ANNALS OF DERMATOLOGY (2020)
Group 2 Innate Lymphoid Cells (ILC2): Type 2 Immunity and Helminth Immunity
De'Broski R. Herbert et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Evidence on the direct correlation between miR-31 and IL-22 axis in IMQ-induced psoriasis
Florence Abdallah et al.
EXPERIMENTAL DERMATOLOGY (2019)
Pruritus in Autoimmune and Inflammatory Dermatoses
Claudia Zeidler et al.
FRONTIERS IN IMMUNOLOGY (2019)
Role of the Pruritic Cytokine IL-31 in Autoimmune Skin Diseases
Bernhard F. Gibbs et al.
FRONTIERS IN IMMUNOLOGY (2019)
IL-4 Augments IL-31/IL-31 Receptor Alpha Interaction Leading to Enhanced Ccl 17 and Ccl 22 Production in Dendritic Cells: Implications for Atopic Dermatitis
Sho Miake et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Influence of Itch and Pain on Sleep Quality in Atopic Dermatitis and Psoriasis
Karolina Kaaz et al.
ACTA DERMATO-VENEREOLOGICA (2019)
European S2k Guideline on Chronic Pruritus In cooperation with the European Dermatology Forum (EDF) and the European Academy of Dermatology and Venereology (EADV)
Elke Weisshaar et al.
ACTA DERMATO-VENEREOLOGICA (2019)
Interleukin-33 (IL-33): A nuclear cytokine from the IL-1 family
Corinne Cayrol et al.
IMMUNOLOGICAL REVIEWS (2018)
Assessment of IL-31 levels and disease severity in children with atopic dermatitis
D. Ozceker et al.
ALLERGOLOGIA ET IMMUNOPATHOLOGIA (2018)
British Association of Dermatologists' guidelines for the investigation and management of generalized pruritus in adults without an underlying dermatosis, 2018
G. W. M. Millington et al.
BRITISH JOURNAL OF DERMATOLOGY (2018)
Modulation of the IL-33/IL-13 Axis in Obesity by IL-13Rα2
Jennifer Duffen et al.
JOURNAL OF IMMUNOLOGY (2018)
The Genetics of Chronic Itch: Gene Expression in the Skin of Patients with Atopic Dermatitis and Psoriasis with Severe Itch
Leigh A. Nattkemper et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2018)
Dupilumab: A review of its use in the treatment of atopic dermatitis
Melinda J. Gooderham et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2018)
Itch: From mechanism to (novel) therapeutic approaches
Gil Yosipovitch et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2018)
New Interleukins in Psoriasis and Psoriatic Arthritis Patients: The Possible Roles of Interleukin-33 to Interleukin-38 in Disease Activities and Bone Erosions
Jiang Li et al.
DERMATOLOGY (2017)
Interleukin 31 and skin diseases: A systematic review
Sebastiano Gangemi et al.
ALLERGY AND ASTHMA PROCEEDINGS (2017)
Atopic dermatitis and psoriasis: two different immune diseases or one spectrum?
Emma Guttman-Yassky et al.
CURRENT OPINION IN IMMUNOLOGY (2017)
Psoriasis and Atopic Dermatitis
Christopher E. M. Griffiths et al.
DERMATOLOGY AND THERAPY (2017)
Serum IL-33 levels are increased in patients with psoriasis
A. Mitsui et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2016)
Mediators of Chronic Pruritus in Atopic Dermatitis: Getting the Itch Out?
Nicholas K. Mollanazar et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2016)
Pruritus in psoriasis: An update
J. C. Szepietowski et al.
EUROPEAN JOURNAL OF PAIN (2016)
INTERLEUKIN-13 AS AN IMPORTANT CYTOKINE: A REVIEW ON ITS ROLES IN SOME HUMAN DISEASES
Narges Seyfizadeh et al.
ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA (2015)
IL-33 Enhances Host Tolerance to Candida albicans Kidney Infections through Induction of IL-13 Production by CD4+ T Cells
Vuvi G. Tran et al.
JOURNAL OF IMMUNOLOGY (2015)
Human IL-31 is induced by IL-4 and promotes TH2-driven inflammation
Bryony Stott et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
Correlation between serum interleukin-31 level and the severity of disease in children with atopic dermatitis
Katarzyna Siniewicz-Luzenczyk et al.
POSTEPY DERMATOLOGII I ALERGOLOGII (2013)
IL-33 is secreted by psoriatic keratinocytes and induces pro-inflammatory cytokines via keratinocyte and mast cell activation
Anna Balato et al.
EXPERIMENTAL DERMATOLOGY (2012)
IL-33 Induces IL-13-Dependent Cutaneous Fibrosis
Andrew L. Rankin et al.
JOURNAL OF IMMUNOLOGY (2010)
Enhanced expression levels of IL-31 correlate with IL-4 and IL-13 in atopic and allergic contact dermatitis.
Mark M. Neis et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2006)